Interrupted vaccination schedules: general principles

Guidance on how to manage interrupted vaccination schedules Interrupted vaccination schedules: general principles

The COVID-19 pandemic has led to many international travel plans being put on hold. However, as travel restrictions are gradually eased, travellers with incomplete vaccine courses are likely to attend to complete schedules.

The immune response that occurs following vaccination is complex. A vaccine contains one or more weakened, inactivated or engineered agents (antigens) that resemble the disease-causing organism(s). Generally, in a person with a healthy immune system, vaccination induces an immune response to the antigen in the vaccine resulting in antibody production and protection, without causing the disease. Furthermore, specialist memory cells enable the immune system to recognise and quickly respond when exposed to natural infections (immune memory) [1, 2].

Some travel related vaccines only need one dose to induce an immune response, which may be relatively short-lasting (e.g., injectable typhoid vaccine) or confer long-lasting immunity, and effective immune memory (e.g. yellow fever). For others a primary course of vaccine, requiring multiple doses given over a specified period, is required (e.g., hepatitis B, Japanese encephalitis, oral typhoid, poliomyelitis, rabies), with a re-enforcing (‘booster’) dose recommended at a defined period following the primary course to maintain immunity (where the traveller continues to be at risk) [1, 2].

Studies show that vaccines given to the recommended schedule provide the best protection. Therefore, for all vaccines, it is best practice to complete the primary course and receive a booster dose (if indicated) at the recommended time intervals [1]. However, in some circumstances this may not be possible e.g., if travel is postponed, the traveller fails to return as directed or during exceptional times such as the current COVID-19 pandemic when clinical activities are reprioritised [3].

General principles

Keep to the recommended vaccination schedule

Clinical studies following vaccine development determine which vaccine schedule (spacing between vaccines and interval to reinforcing dose) offers the best chance for immunity to develop. Recommended schedules should be adhered to wherever possible [4].

Every dose in a course counts

A course of vaccine may require multiple doses over a specified time period and each dose is important. The first vaccine in a multiple dose schedule begins to prime the immune system. However, further doses, given at the recommended intervals, are necessary for immunity to develop.

For interrupted schedules

If the individual still requires protection, start where the course was left. Immune memory already laid down by previous dose(s) of a vaccine means that repeating doses or re-starting a course of vaccine is rarely necessary (but also see ‘exceptions’). For most vaccines, where a record exists of previous doses, start where the course was left and complete the course, observing the same interval between future doses as indicated by the manufacturer [1, 2].

Lengthening intervals between doses

The effectiveness of vaccines given outside the recommended schedule may not have been evaluated in clinical studies [1]; although, generally, the immune response is not impaired where doses are given at longer than the recommended interval (but also see ‘exceptions’) [1].

Shortening intervals between doses

Where doses are given at less than the recommended interval, the immune response may be impaired. Where possible, avoid shortening the interval unless a recognised rapid schedule is recommended by the manufacturer or the relevant chapter in immunisation against infectious disease [1, 5]. If vaccine has been administered with a reduced interval between doses, is it advisable to seek further support, on a case-by-case basis.

For vaccines given according to the UK schedule, further guidance about schedule flexibility is provided in chapter 11 of immunisation against infectious disease, the ‘Green book’.


Re-starting a course of vaccine

In some circumstances such as where the effect of interrupted doses in a schedule may not be not clear (i.e. oral typhoid vaccine or oral cholera vaccine - Dukoral) re-starting a course may be recommended. Additionally, where there is no, or inadequate documentation of previous doses, re-starting a course of vaccine may be an option after individual risk assessment, to be certain that a person is protected. Further advice on a case-by-case basis may be needed.

Health professionals can call the NaTHNaC Advice Line for further guidance.


First Published :   30 Mar 2021
Last Updated :   30 Mar 2021

COVID-19: Vaccines

Information on COVID-19 vaccines in the UK and vaccination programmes worldwide Read more

Educational events

A list of courses, conferences and study days of relevance to UK health professionals working, or wishing to work, in the field of travel medicine Read more

COVID-19: Resources

Current coronavirus advice from NaTHNaC, PHE and FCDO, with links to international information sources Read more

COVID-19: Travel risk assessment

Factors health professionals should consider when advising those who are planning international travel during the COVID-19 pandemic Read more
Back to Top